CN Patent

CN103181893A — 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法

Assigned to United Therapeutics Corp · Expires 2013-07-03 · 13y expired

What this patent protects

本发明提供优选地针对革兰氏阴性细菌具有杀菌活性的药物制剂用缓冲液。所述缓冲液具有大于约10的pH或小于约4.5的pH以及低缓冲容量。本发明还提供该缓冲液在降低哺乳动物体内血流感染发生率方面的使用方法。

USPTO Abstract

本发明提供优选地针对革兰氏阴性细菌具有杀菌活性的药物制剂用缓冲液。所述缓冲液具有大于约10的pH或小于约4.5的pH以及低缓冲容量。本发明还提供该缓冲液在降低哺乳动物体内血流感染发生率方面的使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN103181893A
Jurisdiction
CN
Classification
—
Expires
2013-07-03
Drug substance claim
No
Drug product claim
No
Assignee
United Therapeutics Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.